Brief: Sharon Bio Medicine's Taloja plant gets USFDA approval
Sept 20 (Reuters) - Sharon Bio Medicine Ltd SHBM.NS : * Clarifies on news item "USFDA approves Sharon Bio's Taloja API plant" * Got EIR from USFDA for API plant at Maharashtra * Payment for GDUFA fees is pending and supply to US cannot be done * The API plant is now approved by the USFDA * Source text: http://bit.ly/2cjbvga * Further company coverage SHBM.NS ((Bangalore.newsroom@thomsonreuters.com))
Recent news on Sharon Bio-Medicine
See all newsBrief: Sharon Bio-Medicine Says Operations At Manufacturing Unit In Maharashtra Have Been Suspended Due To Fire Accident
Brief: India's Sharon Bio-Medicine Dec-Quarter Profit Rises
Brief: Sharon Bio-Medicine Trade Union In API Manufacturing Facility At Taloja, Mumbai Has Given Call For Indefinite Strike From Jan 3
Brief: India's Sharon Bio-Medicine Ltd Sept-Quarter Profit Rises
Media: Piramal, Cadila among 32 companies in race to buy India's Sharon Bio-Medicine - ET